Description
Taylor & Francis Atherosclerotic Cardiovascular Disease Hemostasis and Endothelial Function 1992 Edition by R B Francis, Robert B Francis
This monograph covers all aspects of the roles that the haemostatic system and endothelial cells play in the pathogenesis and treatment of atherosclerotic cardiovascular disease (ASCVD) and its major clinical implications, including stroke, myocardial infarction, and peripheral vascular disease.Providing complementary perspectives from international experts, Atherosclerotic Cardiovascular Disease, Haemostasis, and Endothelial Function offers in-depth discussions of: coagulation factors and endogenous coagulation inhibitors in ASCVD the contribution of impaired fibrinolysis to the pathogenesis of ASCVD the relationship of lipid abnormalities and hyperinsulinemia to altered coagulation and fibrinolysis elevated plasma homocysteine antiphospholipid antibodies and ASCVD altered platelet activity in ASCVD and vasoconstrictive and vasodilating factors derived from the endothelium in ASCVD.With over 1700 literature citations and figures, this reference is intended for cardiologists, haematologists, physiologists epidemiologists, internists, and medical school students in these disciplines. Table of contents : - Fibrinogen and other clotting factors in cardiovascular disease, T.W. Meade the tissue factor pathway and cardiovascular disease, Hans Prydz von Willebrand factor and atherosclerotic cardiovascular disease, Lina Badimon and Valentin Fuster the natural anticoagulant proteins and cardiovascular disease, Philip C. Comp Fibrinolysis and atherosclerotic cardiovascular disease, Anders Hamsten and Bjorn Wiman Lipoprotein(a), fibrinolysis, and cardiovascular disease, Angelo M. Scanu Hyperinsulinaemia and its effects on coagulation and Fibrinolysis in cardiovascular disease, Philippe Vague and Irene Juhan-Vague plasma homocysteine and cardiovascular disease, Per Magne Ueland et al antiphospholipid antibodies and cardiovascular disease, E. Nigel Harris platelet hyperreactivity and cardiovascular disease Mieke D. Trip platelet-activating factor and atherosclerotic cardiovascular disease, Diana M. Stafforini et al Endothelium-derived vasoactive substances and atherosclerotic cardiovascular disease, Paolo Golino et al.